Skip to main content

Table 6 Median and range for EDSS by treatment with p-value and standardized effect size, d

From: Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS)

Measure

Treatment

A: Placebo

B: Melatonin

p

d

Median

Range

Median

Range

Visual

1.0

0–4

1.5

0–4

0.056

0.539

Brainstem

1.0

0–2

1.0

0–2

0.288

0.292

Sensory

3.0

0–4

3.0

0–3

0.090

0.474

Pyramidal

2.0

0–3

2.0

0–3

0.386

0.238

Cerebellar

2.0

1–4

2.0

0–3

0.181

0.370

Cerebral

2.0

0–3

2.0

0–3

0.653

0.123

Bladder and Bowel

2.0

1–3

2.0

0–3

0.674

0.115

Ambulatory

1.0

0–9

1.0

0–9

1.00

0.000

EDSS

4.0

1.5–8

4.0

3–8

0.209

0.347

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us